Actimis Pharmaceuticals (Acquired by Boehringer Ingelheim)
Actimis Pharmaceuticals is a private pharmaceutical company based in California focusing on inflammatory diseases.
| Company | Actimis Pharmaceuticals |
|---|---|
| URL | http://www.actimis.com/ |
Boehringer Ingelheim GmbH today announced an agreement to acquire Actimis Pharmaceuticals, Inc. The acquisition will occur through a structured buyout in which Boehringer Ingelheim will acquire shares of Actimis depending on the achievement of several successive milestones with Actimis' leading asthma compound AP768.
Bayer Healthcare AG Spin-out, Actimis Pharmaceuticals, Completes $6 Million Series A Financing
San Diego, CA, April 28, 2005 - Actimis Pharmaceuticals, Inc., a startup company dedicated to developing and commercializing small molecule therapeutics for respiratory and inflammatory diseases, today announced a $6 million private placement ...
06/17/2008 | Taro InabaBoehringer Ingelheim announced an agreement to acquire Actimis Pharmaceuticals, Inc. one of our portfolio firms.
11/01/2007 | Nobuhiro Shimizu【Announcement of the Establishment of Beijing Office】
We are pleased to announce that Mitsui Ventures has opened a new office in Beijing in September2007.
07/18/2007 | Taro InabaMitsui Ventures Launching a New Approach to Seed Financing